Cargando…
SimB16: Modeling Induced Immune System Response against B16-Melanoma
Immunological therapy of progressive tumors requires not only activation and expansion of tumor specific cytotoxic T lymphocytes (CTLs), but also an efficient effector phase including migration of CTLs in the tumor tissue followed by conjugation and killing of target cells. We report the application...
Autores principales: | Pappalardo, Francesco, Forero, Ivan Martinez, Pennisi, Marzio, Palazon, Asis, Melero, Ignacio, Motta, Santo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3197530/ https://www.ncbi.nlm.nih.gov/pubmed/22028894 http://dx.doi.org/10.1371/journal.pone.0026523 |
Ejemplares similares
-
A methodological approach for using high-level Petri Nets to model the immune system response
por: Pennisi, Marzio, et al.
Publicado: (2016) -
Agent-Based Modeling of the Immune System: NetLogo, a Promising Framework
por: Chiacchio, Ferdinando, et al.
Publicado: (2014) -
Computational Modeling of PI3K/AKT and MAPK Signaling Pathways in Melanoma Cancer
por: Pappalardo, Francesco, et al.
Publicado: (2016) -
Chamaejasmin B Decreases Malignant Characteristics of Mouse Melanoma B16F0 and B16F10 Cells
por: Si, Lingling, et al.
Publicado: (2020) -
Metastatic inefficiency in mice bearing B16 melanomas.
por: Weiss, L., et al.
Publicado: (1982)